ULTRALIFE CORP (ULBI) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:ULBI • US9038991025

6.53 USD
+0.19 (+3%)
Last: Feb 9, 2026, 04:10 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026
Revenue
YoY % growth
ULBI revenue by date.ULBI revenue by date.
131.8M
34.08%
158.644M
20.37%
164.456M
3.66%
215.93M
31.30%
229.4M
6.24%
EBITDA
YoY % growth
ULBI ebitda by date.ULBI ebitda by date.
4.56M
28.81%
13.386M
193.55%
15.416M
15.17%
23.256M
50.86%
25.296M
8.77%
EBIT
YoY % growth
ULBI ebit by date.ULBI ebit by date.
100K9.475M
9,375.00%
11.259M
18.83%
16.83M
49.48%
19.278M
14.55%
Operating Margin
ULBI operating margin by date.ULBI operating margin by date.
0.08%5.97%6.85%7.79%8.40%
EPS
YoY % growth
ULBI eps by date.ULBI eps by date.
0.05
600.00%
0.56
1,020.00%
0.46
-17.86%
0.78
68.52%
0.95
22.37%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.28
2,654.00%
0.16
25.54%
0.21
206.00%
0.26
464.29%
0.31
11.11%
Revenue
Q2Q % growth
58.14M
32.58%
53.448M
5.32%
56.1M
15.52%
57.12M
31.70%
62.73M
7.89%
EBITDA
Q2Q % growth
6.018M
-9.84%
6.018M
23.34%
6.018M
16.49%
6.63M
84.89%
6.732M
11.86%
EBIT
Q2Q % growth
5.304M
110.64%
4.182M
18.67%
4.284M
79.02%
4.794M
891.09%
6.018M
13.46%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.07
-450.00%
0.22-0.29-131.19%
Q2 2025
Q2Q % growth
0.07
-68.18%
0.14-0.07-50.98%
Q1 2025
Q2Q % growth
0.13
-38.10%
0.15-0.02-15.03%
Q4 2024
Q2Q % growth
0.01
-94.44%
0.15-0.14-93.46%
Q3 2024
Q2Q % growth
0.02
-80.00%
0.21-0.19-90.66%
Q2 2024
Q2Q % growth
0.22
-24.14%
0.140.0854.06%
Q1 2024
Q2Q % growth
0.21
2,200.00%
0.100.11105.88%
Q4 2023
Q2Q % growth
0.18
350.00%
0.090.0996.08%
Q3 2023
Q2Q % growth
0.10
1,100.00%
0.100.00-1.96%
Q2 2023
Q2Q % growth
0.29
866.67%
0.040.25610.78%
Q1 2023
Q2Q % growth
-0.01 -0.100.0990.20%
Q4 2022
Q2Q % growth
0.04
166.67%
0.09-0.05-56.43%
Q3 2022
Q2Q % growth
-0.01
75.00%
0.04-0.05-124.51%
Q2 2022
Q2Q % growth
0.03
-40.00%
0.010.02194.12%
Q1 2022
Q2Q % growth
-0.01
-125.00%
-0.050.0480.39%
Q4 2021
Q2Q % growth
-0.06
-135.29%
-0.04-0.02-47.06%
Q3 2021
Q2Q % growth
-0.04 0.08-0.12-149.02%
Q2 2021
Q2Q % growth
0.05 0.09-0.04-45.53%
Q1 2021
Q2Q % growth
0.04 0.06-0.02-34.64%
ULBI Yearly EPS VS EstimatesULBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.2 0.4 0.6 0.8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
43.37M
21.51%
54.06M-10.69M-19.77%
Q2 2025
Q2Q % growth
48.561M
12.98%
52.02M-3.459M-6.65%
Q1 2025
Q2Q % growth
50.746M
21.03%
48.96M1.786M3.65%
Q4 2024
Q2Q % growth
43.852M
-1.57%
40.8M3.052M7.48%
Q3 2024
Q2Q % growth
35.694M
-9.61%
43.86M-8.166M-18.62%
Q2 2024
Q2Q % growth
42.983M
0.68%
42.84M143K0.33%
Q1 2024
Q2Q % growth
41.927M
31.37%
38.76M3.167M8.17%
Q4 2023
Q2Q % growth
44.55M
23.37%
39.78M4.77M11.99%
Q3 2023
Q2Q % growth
39.488M
18.83%
40.29M-802K-1.99%
Q2 2023
Q2Q % growth
42.692M
32.87%
32.64M10.052M30.80%
Q1 2023
Q2Q % growth
31.916M
5.09%
27.54M4.376M15.89%
Q4 2022
Q2Q % growth
36.11M
51.98%
37.74M-1.63M-4.32%
Q3 2022
Q2Q % growth
33.23M
52.71%
33.66M-430K-1.28%
Q2 2022
Q2Q % growth
32.13M
20.02%
32.13M3.725290298461914e-90.00%
Q1 2022
Q2Q % growth
30.37M
16.94%
26.112M4.258M16.31%
Q4 2021
Q2Q % growth
23.76M
-18.01%
21.42M2.34M10.92%
Q3 2021
Q2Q % growth
21.76M
-10.67%
27.54M-5.78M-20.99%
Q2 2021
Q2Q % growth
26.77M
-6.27%
29.58M-2.81M-9.50%
Q1 2021
Q2Q % growth
25.97M
0.62%
27.234M-1.264M-4.64%
ULBI Yearly Revenue VS EstimatesULBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% 0% 0% 0%